Phoma spp. an untapped treasure of cytotoxic compounds: current status and perspectives
The genus Phoma has been explored for a wide range of secondary metabolites signifying a huge range of bioactivities. Phoma sensu lato is a major group that secretes several secondary metabolites. The genus Phoma mainly includes Phoma macrostoma , P. multirostrata , P. exigua , P. herbarum , P. beta...
Gespeichert in:
Veröffentlicht in: | Applied microbiology and biotechnology 2023-08, Vol.107 (16), p.4991-5001 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The genus
Phoma
has been explored for a wide range of secondary metabolites signifying a huge range of bioactivities.
Phoma sensu lato
is a major group that secretes several secondary metabolites. The genus
Phoma
mainly includes
Phoma macrostoma
,
P. multirostrata
,
P. exigua
,
P. herbarum
,
P. betae
,
P. bellidis
,
P. medicaginis
,
P. tropica
, and many more species from the genus that are continuously being identified for their potential secondary metabolites. The metabolite spectrum includes bioactive compounds like phomenon, phomin, phomodione, cytochalasins, cercosporamide, phomazines, and phomapyrone reported from various
Phoma
spp. These secondary metabolites show a broad range of activities including antimicrobial, antiviral, antinematode, and anticancer. The present review is aimed to emphasize the importance of
Phoma sensu lato
fungi, as a natural source of biologically active secondary metabolites, and their cytotoxic activities. So far, cytotoxic activities of
Phoma
spp. have not been reviewed; hence, this review will be novel and useful for the readers to develop
Phoma
-derived anticancer agents.
Key points
•
Different Phoma spp. contain a wide variety of bioactive metabolites.
•
These Phoma spp. also secrete cytotoxic and antitumor compounds.
•
The secondary metabolites can be used for the development of anticancer agents. |
---|---|
ISSN: | 0175-7598 1432-0614 |
DOI: | 10.1007/s00253-023-12635-9 |